alexa Apollina Goel | OMICS International | University of Iow
ISSN: 2329-6631

Journal of Developing Drugs
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Apollina Goel
Apollina Goel Apollina Goel
Department of Radiation Oncology
University of Iowa

Dr. Goel is currently an Assistant Professor in the Free Radical and Radiation Biology Program within the Department of Radiation Oncology at the University of Iowa, USA. Dr. Goel received her undergraduate degree in Biotechnology from Pune University, India. She pursued her doctorate in Biotechnology at Institute of Microbial Technology, India. Dr. Goel then undertook post-doctoral studies at University of Nebraska Medical center and at Mayo Clinic, USA. During her postdoctoral research at UNMC, she developed a radioimmunotherapy approach to the treatment of solid tumors. Subsequently she spent two years at Mayo Clinic studying the interactions between genes and transcription factors. During her next two years at Mayo clinic, Dr. Goel combined her basic and translational experience in multiple myeloma and non-Hodgkins lymphoma models. Dr. Goel is currently pursuing targeted radiotherapy (using bone-seeking radiotherapy and oncolytic viruses encoding for human sodium iodide symporter gene) with molecular drugs to target these B-cell malignancies. Dr. Goel has published more than 25 papers in reputed journals, and authored several review articles and book chapters. She is serving as grant reviewer for several agencies and scientific reviewer for several journals.

Research Interest

Chemo-radiotherapy for hematological malignancies, Understanding and circumventing resistance to radiotherapy in multiple myeloma and B-cell lymphoma.


Global Speakers in the subject

Global Experts in the subject


Combination Therapy for Multiple Myeloma: How Far Have We Come?
Apollina Goel
Editorial: J Dev Drugs 2012, 1:e113
DOI: 10.4172/2329-6631.1000e113
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version